These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 7644931
1. Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials. Muggia FM, Vafai D, Natale R, Israel V, Zaretsky S, McRae A, Rogers M, Jeffers S. Semin Oncol; 1995 Aug; 22(4 Suppl 9):63-6. PubMed ID: 7644931 [Abstract] [Full Text] [Related]
2. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF. Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025 [Abstract] [Full Text] [Related]
11. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial. Meerpohl HG, du Bois A, Luck HJ, Kühnle H, Möbus V, Kreienberg R, Bauknecht T, Köchli O, Bochtler H, Diergarten K. Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-17-S2-22. PubMed ID: 9045330 [Abstract] [Full Text] [Related]
12. Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study. Belani CP, Aisner J, Hiponia D, Ramanathan R. Semin Oncol; 1996 Oct; 23(5 Suppl 12):19-21. PubMed ID: 8941406 [Abstract] [Full Text] [Related]
13. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer. Giaccone G, Huizing M, Postmus PE, ten Bokkel Huinink WW, Koolen M, van Zandwijk N, Vermorken JB, Beijnen JH, Dalesio O, Pinedo HM. Semin Oncol; 1995 Aug; 22(4 Suppl 9):78-82. PubMed ID: 7544030 [Abstract] [Full Text] [Related]
14. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials. DeVore RF, Jagasia M, Johnson DH. Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116 [Abstract] [Full Text] [Related]
15. Paclitaxel and carboplatin in inoperable non-small cell lung cancer. Kosmidis P, Mylonakis N, Fountzilas G, Samantas E, Athanasiadis A, Skarlos D. Semin Oncol; 1996 Dec; 23(6 Suppl 16):68-70. PubMed ID: 9007126 [Abstract] [Full Text] [Related]
16. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC). Glorieux P, Ortmanns P, Marien S, Degives R, Degraeve D, Potvin M, Grauwels D, Schallier D. Anticancer Res; 2001 Dec; 21(2B):1487-94. PubMed ID: 11396237 [Abstract] [Full Text] [Related]
17. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer. Natale RB. Semin Oncol; 1996 Dec; 23(6 Suppl 16):51-4. PubMed ID: 9007122 [Abstract] [Full Text] [Related]
18. A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center study. Bunn PA, Kelly K. Semin Oncol; 1995 Aug; 22(4 Suppl 9):2-6. PubMed ID: 7644924 [Abstract] [Full Text] [Related]
19. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer. Meerpohl HG, du Bois A, Kühnle H, Lück HJ, Kreienberg R, Möbus V, Bauknecht T, Köchli O, Bochtler H, Diergarten K. Semin Oncol; 1995 Dec; 22(6 Suppl 15):7-12. PubMed ID: 8643973 [Abstract] [Full Text] [Related]